Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.11 trillion and total revenue of $110.3 billion.
Market Cap
1.11T
Revenue
110.3B
Profits
-39.87B
PE Ratio
n/a
Profit Margin
-36.14%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 107.66B | -1.60% | 1,059,479 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 69.83B | -6.21% | 1,834,987 | 14.92B |
| 3 | ARGX | argenx SE | 47.71B | 0.13% | 423,340 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.19B | -0.30% | 1,562,151 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 32.32B | -2.47% | 208,704 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 29.56B | -2.96% | 2,790,639 | - |
| 7 | RPRX | Royalty Pharma plc | 29.34B | -0.10% | 3,050,541 | 2.38B |
| 8 | INSM | Insmed Incorporated | 29.15B | 0.07% | 1,487,751 | 606.42M |
| 9 | BNTX | BioNTech SE | 25.69B | -0.48% | 544,170 | 3.37B |
| 10 | INCY | Incyte Corporation | 19.80B | 1.39% | 2,242,761 | 5.36B |
| 11 | ROIV | Roivant Sciences Ltd. | 19.70B | -0.90% | 4,372,410 | 13.31M |
| 12 | MRNA | Moderna, Inc. | 18.13B | -3.01% | 5,478,399 | 1.94B |
| 13 | SMMT | Summit Therapeutics Inc. | 16.17B | -2.02% | 2,760,338 | - |
| 14 | GMAB | Genmab A/S | 15.90B | -2.54% | 1,837,689 | 3.72B |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.75B | 1.76% | 2,791,597 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 13.61B | -0.81% | 1,671,887 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.36B | 4.25% | 3,675,236 | 1.06B |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.31B | -1.99% | 594,443 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.90B | 0.37% | 153,842 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.35B | -0.53% | 1,857,471 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.48B | 1.71% | 1,639,719 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.88B | 0.57% | 1,045,047 | 1.09B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 9.41B | -0.57% | 758,700 | 638.50M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.00B | 0.39% | 363,581 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 8.66B | -3.30% | 860,770 | 5.37M |
| 26 | PCVX | Vaxcyte, Inc. | 8.25B | -2.40% | 1,161,198 | - |
| 27 | TECH | Bio-Techne Corporation | 8.13B | -2.92% | 1,376,342 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 7.79B | -2.79% | 390,288 | - |
| 29 | KRYS | Krystal Biotech, Inc. | 7.65B | -3.46% | 213,873 | 389.13M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.47B | -1.25% | 1,230,567 | 1.40B |
| 31 | CYTK | Cytokinetics, Incorporated | 7.40B | -1.83% | 2,375,173 | 88.04M |
| 32 | IBRX | ImmunityBio, Inc. | 7.19B | - | 9,274,435 | 113.29M |
| 33 | ACLX | Arcellx, Inc. | 6.75B | - | 16,117,821 | 22.29M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.65B | -2.79% | 754,528 | 39.21M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.29B | -2.66% | 576,819 | 46.02M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 6.20B | 4.75% | 1,808,285 | - |
| 37 | COGT | Cogent Biosciences, Inc. | 6.13B | -1.29% | 1,272,749 | - |
| 38 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | -0.04% | 1,859,062 | - |
| 39 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.03% | 1,666,063 | 15.00M |
| 40 | BLTE | Belite Bio, Inc | 6.08B | -2.66% | 37,774 | - |
| 41 | APGE | Apogee Therapeutics, Inc. | 6.06B | -3.91% | 679,709 | - |
| 42 | CELC | Celcuity Inc. | 5.75B | -0.89% | 861,790 | - |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.74B | 0.21% | 768,125 | 521.31M |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.61B | -2.45% | 580,787 | 189.76M |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.52B | -0.92% | 1,754,804 | - |
| 46 | IMVT | Immunovant, Inc. | 5.49B | -0.15% | 1,767,252 | - |
| 47 | CGON | CG Oncology, Inc. | 5.47B | -1.22% | 636,809 | 4.04M |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.39B | 2.24% | 1,725,130 | 7.50M |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.35B | -8.13% | 4,238,877 | 1.73B |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | -0.10% | 2,721,413 | 1.00B |
| 51 | CAI | Caris Life Sciences, Inc. | 5.02B | -3.63% | 2,496,346 | 812.03M |
| 52 | CORT | Corcept Therapeutics Incorporated | 5.00B | -0.06% | 1,235,736 | 761.41M |
| 53 | TGTX | TG Therapeutics, Inc. | 4.96B | -2.89% | 1,829,165 | 616.29M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.88B | -2.59% | 1,539,774 | 3.51M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.55B | -0.20% | 510,005 | 2.04M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 4.51B | -3.21% | 252,222 | 268.09M |
| 57 | LEGN | Legend Biotech Corporation | 4.21B | -3.35% | 1,561,935 | 1.03B |
| 58 | KLRA | Kailera Therapeutics, Inc. | 4.17B | 3.95% | 681,101 | - |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.02B | 0.76% | 2,581,615 | 7.70M |
| 60 | MANE | Veradermics, Incorporated | 3.98B | 3.35% | 715,520 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.78B | -2.07% | 1,310,393 | 1.07B |
| 62 | TVTX | Travere Therapeutics, Inc. | 3.70B | -1.93% | 1,396,943 | 490.73M |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.63B | -3.27% | 2,949,308 | - |
| 64 | TLX | Telix Pharmaceuticals Limited | 3.63B | -0.10% | 119,229 | 803.79M |
| 65 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.45B | -4.01% | 1,608,084 | 588.99M |
| 66 | ORKA | Oruka Therapeutics, Inc. | 3.42B | -7.96% | 7,921,450 | - |
| 67 | NAMS | NewAmsterdam Pharma Company N.V. | 3.27B | -1.01% | 619,022 | 22.50M |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.27B | -1.74% | 1,211,050 | - |
| 69 | TNGX | Tango Therapeutics, Inc. | 3.18B | -12.25% | 3,871,083 | 62.38M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.03B | -2.70% | 1,121,012 | 247.00M |
| 71 | DNLI | Denali Therapeutics Inc. | 2.95B | -7.28% | 3,000,027 | - |
| 72 | BEAM | Beam Therapeutics Inc. | 2.94B | -3.86% | 1,742,309 | 139.74M |
| 73 | GPCR | Structure Therapeutics Inc. | 2.93B | -5.04% | 1,478,847 | - |
| 74 | ALMS | Alumis Inc. | 2.91B | -4.70% | 1,065,099 | 24.05M |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.88B | -4.13% | 1,547,963 | - |
| 76 | ERAS | Erasca, Inc. | 2.83B | -7.98% | 13,505,200 | - |
| 77 | NKTR | Nektar Therapeutics | 2.81B | -0.73% | 851,435 | 55.23M |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 2.80B | -3.95% | 1,109,012 | 376.07M |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.04% | 2,381,822 | 190.41M |
| 80 | KOD | Kodiak Sciences Inc. | 2.71B | -3.87% | 392,078 | - |
| 81 | IMNM | Immunome, Inc. | 2.60B | -3.21% | 812,185 | 6.94M |
| 82 | TARS | Tarsus Pharmaceuticals, Inc. | 2.58B | -2.29% | 545,468 | 451.36M |
| 83 | VERA | Vera Therapeutics, Inc. | 2.57B | -3.42% | 920,809 | - |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.54B | -1.35% | 491,834 | - |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.52B | -3.28% | 602,776 | 1.55M |
| 86 | IRON | Disc Medicine, Inc. | 2.52B | -1.92% | 585,184 | - |
| 87 | IDYA | IDEAYA Biosciences, Inc. | 2.46B | -3.41% | 1,005,698 | 218.71M |
| 88 | ADMA | ADMA Biologics, Inc. | 2.46B | -2.75% | 4,210,063 | 510.17M |
| 89 | RLAY | Relay Therapeutics, Inc. | 2.38B | -3.53% | 3,651,772 | 15.36M |
| 90 | RARE | Ultragenyx Pharmaceutical Inc. | 2.37B | -1.43% | 2,058,771 | 673.00M |
| 91 | ZLAB | Zai Lab Limited | 2.33B | -6.28% | 699,953 | 460.16M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.17B | -1.90% | 1,450,290 | 2.20B |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 2.11B | -1.27% | 868,436 | - |
| 94 | AAPG | Ascentage Pharma Group International | 2.10B | -2.26% | 5,203 | 82.08M |
| 95 | ADPT | Adaptive Biotechnologies Corporation | 2.08B | -3.63% | 1,261,299 | 276.98M |
| 96 | MESO | Mesoblast Limited | 2.05B | 2.17% | 152,280 | 65.38M |
| 97 | ZYME | Zymeworks Inc. | 2.05B | -0.39% | 824,409 | 105.97M |
| 98 | DFTX | Definium Therapeutics, Inc. | 2.04B | -3.67% | 1,341,986 | - |
| 99 | STOK | Stoke Therapeutics, Inc. | 2.02B | -2.73% | 586,048 | 184.42M |
| 100 | TYRA | Tyra Biosciences, Inc. | 2.01B | -3.64% | 1,174,229 | - |
| 101 | OCUL | Ocular Therapeutix, Inc. | 2.00B | -1.18% | 2,522,630 | 51.95M |
| 102 | AUPH | Aurinia Pharmaceuticals Inc. | 1.99B | -4.74% | 1,301,956 | 283.06M |
| 103 | PHVS | Pharvaris N.V. | 1.95B | 5.71% | 961,560 | - |
| 104 | TRVI | Trevi Therapeutics, Inc. | 1.94B | -0.14% | 1,585,020 | - |
| 105 | CAPR | Capricor Therapeutics, Inc. | 1.88B | -4.47% | 762,250 | 11.13M |
| 106 | GLPG | Galapagos NV | 1.85B | -1.97% | 222,765 | 1.31B |
| 107 | INBX | Inhibrx Biosciences, Inc. | 1.82B | -4.48% | 326,738 | 1.30M |
| 108 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | -2.27% | 2,438,055 | 172.35M |
| 109 | TSHA | Taysha Gene Therapies, Inc. | 1.80B | -0.48% | 2,802,202 | 9.77M |
| 110 | HRMY | Harmony Biosciences Holdings, Inc. | 1.80B | -0.35% | 613,998 | 868.45M |
| 111 | ANAB | AnaptysBio, Inc. | 1.79B | -5.70% | 686,603 | 234.60M |
| 112 | PVLA | Palvella Therapeutics, Inc. | 1.75B | -2.79% | 147,795 | - |
| 113 | RXRX | Recursion Pharmaceuticals, Inc. | 1.74B | -3.23% | 12,199,480 | 74.68M |
| 114 | NRIX | Nurix Therapeutics, Inc. | 1.72B | -2.75% | 834,809 | 71.78M |
| 115 | INVA | Innoviva, Inc. | 1.71B | -2.70% | 564,176 | 411.33M |
| 116 | VCEL | Vericel Corporation | 1.70B | -6.23% | 720,169 | 276.26M |
| 117 | SION | Sionna Therapeutics, Inc. | 1.69B | -5.46% | 317,657 | - |
| 118 | AGIO | Agios Pharmaceuticals, Inc. | 1.64B | 13.10% | 2,797,999 | 66.05M |
| 119 | VIR | Vir Biotechnology, Inc. | 1.63B | -1.95% | 1,308,078 | 68.56M |
| 120 | NBTX | Nanobiotix S.A. | 1.60B | -0.39% | 57,596 | 38.27M |
| 121 | GENB | Generate Biomedicines, Inc. | 1.58B | -0.72% | 283,560 | 31.89M |
| 122 | RAPP | Rapport Therapeutics, Inc. | 1.58B | -2.19% | 229,970 | - |
| 123 | OCS | Oculis Holding AG | 1.57B | -1.01% | 209,461 | 1.51M |
| 124 | ATAI | AtaiBeckley Inc. | 1.51B | -4.85% | 3,603,927 | 4.09M |
| 125 | NUVB | Nuvation Bio Inc. | 1.51B | -4.82% | 3,297,985 | 62.90M |
| 126 | IMTX | Immatics N.V. | 1.50B | -3.36% | 278,461 | 56.67M |
| 127 | GLUE | Monte Rosa Therapeutics, Inc. | 1.50B | -1.53% | 536,552 | 123.67M |
| 128 | ARDX | Ardelyx, Inc. | 1.47B | 0.67% | 3,390,796 | 407.32M |
| 129 | NTLA | Intellia Therapeutics, Inc. | 1.47B | -5.72% | 26,793,596 | 67.67M |
| 130 | PGEN | Precigen, Inc. | 1.46B | 2.49% | 2,904,175 | 9.68M |
| 131 | DMRA | Damora Therapeutics, Inc. | 1.44B | -1.24% | 118,082 | - |
| 132 | MAZE | Maze Therapeutics, Inc. | 1.42B | -1.04% | 412,648 | 2.50M |
| 133 | IMCR | Immunocore Holdings plc | 1.42B | -3.02% | 505,336 | 400.02M |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.39B | -2.92% | 393,414 | - |
| 135 | BHVN | Biohaven Ltd. | 1.38B | -4.27% | 1,762,227 | - |
| 136 | VRDN | Viridian Therapeutics, Inc. | 1.37B | -2.28% | 981,130 | 70.85M |
| 137 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 38.62% | 71,972,282 | 73.62M |
| 138 | IOVA | Iovance Biotherapeutics, Inc. | 1.36B | -2.07% | 8,938,446 | 263.50M |
| 139 | MBX | MBX Biosciences, Inc. | 1.36B | -1.48% | 296,690 | - |
| 140 | WVE | Wave Life Sciences Ltd. | 1.36B | -6.25% | 4,904,581 | 71.80M |
| 141 | MPLT | MapLight Therapeutics, Inc. | 1.33B | -0.07% | 201,211 | - |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.33B | 0.03% | 252,078 | - |
| 143 | NVAX | Novavax, Inc. | 1.30B | 0.63% | 2,865,475 | 1.12B |
| 144 | DBVT | DBV Technologies S.A. | 1.24B | -2.40% | 105,835 | 5.64M |
| 145 | OLMA | Olema Pharmaceuticals, Inc. | 1.23B | -3.08% | 757,801 | - |
| 146 | SVRA | Savara Inc. | 1.23B | -3.39% | 1,100,160 | - |
| 147 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | -7.68% | 2,051,208 | - |
| 148 | GHRS | GH Research PLC | 1.19B | -3.48% | 232,895 | - |
| 149 | PHAR | Pharming Group N.V. | 1.17B | -0.40% | 2,401 | 376.13M |
| 150 | ABCL | AbCellera Biologics Inc. | 1.16B | -8.17% | 12,053,762 | 75.13M |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.16B | -3.30% | 561,029 | - |
| 152 | URGN | UroGen Pharma Ltd. | 1.14B | -3.23% | 492,272 | 109.79M |
| 153 | JBIO | Jade Biosciences, Inc. | 1.10B | -15.61% | 1,195,826 | - |
| 154 | EYPT | EyePoint, Inc. | 1.07B | -4.53% | 805,718 | 31.37M |
| 155 | QURE | uniQure N.V. | 1.05B | -7.31% | 1,674,227 | 16.10M |
| 156 | SEPN | Septerna, Inc. | 1.05B | -3.46% | 347,611 | 45.95M |
| 157 | OMER | Omeros Corporation | 1.05B | -0.75% | 856,129 | - |
| 158 | ZBIO | Zenas BioPharma, Inc. | 1.04B | -2.55% | 498,518 | 10.00M |
| 159 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | -1.15% | 1,080,847 | 291.85M |
| 160 | AKTS | Aktis Oncology, Inc. | 1.03B | 0.65% | 249,882 | 6.50M |
| 161 | IVA | Inventiva S.A. | 1.02B | -1.40% | 146,823 | 7.94M |
| 162 | FTRE | Fortrea Holdings Inc. | 987.36M | -1.86% | 2,963,776 | 2.72B |
| 163 | DSGN | Design Therapeutics, Inc. | 973.81M | 23.26% | 2,691,594 | - |
| 164 | GERN | Geron Corporation | 967.76M | - | 12,001,441 | 183.88M |
| 165 | ANNX | Annexon, Inc. | 957.17M | -1.83% | 2,559,227 | - |
| 166 | ORIC | ORIC Pharmaceuticals, Inc. | 947.38M | -2.18% | 1,341,997 | - |
| 167 | PHAT | Phathom Pharmaceuticals, Inc. | 935.69M | 3.97% | 2,933,991 | 175.11M |
| 168 | MRVI | Maravai LifeSciences Holdings, Inc. | 894.59M | -2.25% | 1,132,968 | 185.74M |
| 169 | SANA | Sana Biotechnology, Inc. | 891.72M | -2.99% | 3,977,581 | - |
| 170 | CTMX | CytomX Therapeutics, Inc. | 881.66M | -1.70% | 2,188,747 | 76.20M |
| 171 | LBRX | LB Pharmaceuticals Inc | 877.19M | -2.52% | 158,130 | - |
| 172 | DRUG | Bright Minds Biosciences Inc. | 865.62M | 0.13% | 164,405 | - |
| 173 | EVMN | Evommune, Inc. | 859.04M | -6.76% | 256,569 | 13.00M |
| 174 | TBPH | Theravance Biopharma, Inc. | 858.39M | -0.54% | 297,553 | 107.46M |
| 175 | JANX | Janux Therapeutics, Inc. | 858.33M | -2.69% | 942,909 | 10.00M |
| 176 | XNCR | Xencor, Inc. | 852.20M | -4.36% | 903,081 | 125.58M |
| 177 | ANRO | Alto Neuroscience, Inc. | 851.78M | -0.69% | 146,588 | - |
| 178 | MNKD | MannKind Corporation | 849.19M | -1.43% | 3,009,808 | 348.97M |
| 179 | SLS | SELLAS Life Sciences Group, Inc. | 838.65M | -4.30% | 3,491,471 | - |
| 180 | MGTX | MeiraGTx Holdings plc | 828.39M | -1.43% | 835,521 | 81.39M |
| 181 | TRAX | First Tracks Biotherapeutics, Inc. | 821.46M | 17.91% | 714,315 | - |
| 182 | ABUS | Arbutus Biopharma Corporation | 813.36M | -0.48% | 1,258,576 | 14.08M |
| 183 | SPRY | ARS Pharmaceuticals, Inc. | 778.49M | -1.26% | 1,071,839 | 84.28M |
| 184 | CGEM | Cullinan Therapeutics, Inc. | 777.76M | 0.31% | 726,205 | - |
| 185 | KURA | Kura Oncology, Inc. | 776.67M | -0.91% | 1,233,660 | 67.48M |
| 186 | RLMD | Relmada Therapeutics, Inc. | 773.03M | 1.80% | 846,904 | - |
| 187 | VOR | Vor Biopharma Inc. | 760.22M | -2.43% | 500,105 | - |
| 188 | TENX | Tenax Therapeutics, Inc. | 752.46M | -12.47% | 548,137 | - |
| 189 | SGP | SpyGlass Pharma, Inc. | 739.73M | -3.78% | 42,976 | - |
| 190 | ABSI | Absci Corporation | 732.16M | -3.09% | 4,013,011 | 2.80M |
| 191 | ALLO | Allogene Therapeutics, Inc. | 725.79M | -3.65% | 6,492,173 | 22.00K |
| 192 | CBIO | Crescent Biopharma, Inc. | 695.82M | -12.60% | 212,222 | 10.84M |
| 193 | SLDB | Solid Biosciences Inc. | 693.81M | -5.37% | 1,132,346 | - |
| 194 | FBRX | Forte Biosciences, Inc. | 686.12M | 6.21% | 323,508 | - |
| 195 | GYRE | Gyre Therapeutics, Inc. | 671.16M | -4.17% | 47,525 | 116.59M |
| 196 | LXRX | Lexicon Pharmaceuticals, Inc. | 656.70M | -6.63% | 1,607,785 | 49.80M |
| 197 | DRTS | Alpha Tau Medical Ltd. | 648.63M | 0.96% | 248,863 | - |
| 198 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 645.06M | -8.41% | 569,449 | - |
| 199 | ARVN | Arvinas, Inc. | 628.10M | -3.91% | 604,902 | 262.60M |
| 200 | PRME | Prime Medicine, Inc. | 625.32M | -4.34% | 1,410,175 | 4.63M |
| 201 | ACRS | Aclaris Therapeutics, Inc. | 624.30M | 5.92% | 1,321,523 | 7.83M |
| 202 | CRMD | CorMedix Inc. | 586.64M | -1.19% | 1,002,627 | 311.71M |
| 203 | STRO | Sutro Biopharma, Inc. | 586.34M | 2.02% | 401,008 | 102.48M |
| 204 | PRTA | Prothena Corporation plc | 585.16M | -5.56% | 397,882 | 9.68M |
| 205 | ZVRA | Zevra Therapeutics, Inc. | 571.64M | -2.32% | 964,555 | 106.47M |
| 206 | OCGN | Ocugen, Inc. | 568.71M | 1.20% | 3,597,009 | 4.41M |
| 207 | ANL | Adlai Nortye Ltd. | 563.60M | 15.78% | 585,441 | 5.00M |
| 208 | PROK | ProKidney Corp. | 549.57M | -0.55% | 617,742 | 893.00K |
| 209 | RIGL | Rigel Pharmaceuticals, Inc. | 539.99M | -4.38% | 265,126 | 294.28M |
| 210 | STTK | Shattuck Labs, Inc. | 535.87M | -5.84% | 697,270 | 1.00M |
| 211 | AGMB | AgomAb Therapeutics NV | 523.43M | 0.94% | 71,479 | - |
| 212 | ALT | Altimmune, Inc. | 510.74M | -4.01% | 4,857,131 | 41.00K |
| 213 | KYTX | Kyverna Therapeutics, Inc. | 508.45M | -3.45% | 756,167 | - |
| 214 | TECX | Tectonic Therapeutic, Inc. | 508.28M | -0.48% | 225,500 | - |
| 215 | UPB | Upstream Bio, Inc. | 500.12M | -3.36% | 415,824 | 2.85M |
| 216 | EIKN | Eikon Therapeutics, Inc. | 493.20M | 6.43% | 226,212 | - |
| 217 | XOMA | XOMA Royalty Corporation | 488.43M | 0.32% | 727,923 | 52.15M |
| 218 | ADCT | ADC Therapeutics SA | 480.78M | 0.27% | 946,804 | 81.36M |
| 219 | LYEL | Lyell Immunopharma, Inc. | 480.56M | -4.14% | 56,029 | 36.00K |
| 220 | FULC | Fulcrum Therapeutics, Inc. | 476.43M | -3.90% | 1,027,672 | 80.00M |
| 221 | ZURA | Zura Bio Limited | 475.35M | -5.47% | 699,665 | - |
| 222 | VSTM | Verastem, Inc. | 474.35M | -1.10% | 2,840,880 | 30.91M |
| 223 | VALN | Valneva SE | 473.10M | -3.62% | 18,915 | 205.07M |
| 224 | ENGN | enGene Therapeutics Inc. | 471.61M | 1.15% | 344,625 | - |
| 225 | OVID | Ovid Therapeutics Inc. | 465.47M | -0.37% | 1,378,334 | 7.25M |
| 226 | MDXG | MiMedx Group, Inc. | 458.33M | -9.26% | 3,429,603 | 389.42M |
| 227 | TRDA | Entrada Therapeutics, Inc. | 457.92M | -1.32% | 140,836 | 25.42M |
| 228 | IMMX | Immix Biopharma, Inc. | 457.49M | 0.35% | 595,436 | - |
| 229 | EPRX | Eupraxia Pharmaceuticals Inc. | 454.46M | 3.23% | 141,282 | - |
| 230 | CADL | Candel Therapeutics, Inc. | 452.67M | -0.32% | 1,333,079 | - |
| 231 | LRMR | Larimar Therapeutics, Inc. | 450.85M | -1.36% | 1,570,460 | - |
| 232 | FDMT | 4D Molecular Therapeutics, Inc. | 449.76M | -6.48% | 850,038 | 85.21M |
| 233 | CTNM | Contineum Therapeutics, Inc. | 449.53M | -3.99% | 100,867 | - |
| 234 | DNA | Ginkgo Bioworks Holdings, Inc. | 436.55M | -4.46% | 1,270,178 | 170.16M |
| 235 | RGNX | REGENXBIO Inc. | 433.58M | -3.34% | 654,053 | 170.44M |
| 236 | AVIR | Atea Pharmaceuticals, Inc. | 432.62M | -2.69% | 379,667 | - |
| 237 | AURA | Aura Biosciences, Inc. | 432.06M | -3.30% | 182,851 | - |
| 238 | PRLD | Prelude Therapeutics Incorporated | 429.36M | -2.73% | 454,123 | 12.14M |
| 239 | LXEO | Lexeo Therapeutics, Inc. | 420.81M | -2.24% | 365,641 | - |
| 240 | CLYM | Climb Bio, Inc. | 419.41M | -5.18% | 1,225,355 | - |
| 241 | ASMB | Assembly Biosciences, Inc. | 418.45M | -2.48% | 64,891 | 72.30M |
| 242 | VNDA | Vanda Pharmaceuticals Inc. | 416.71M | 3.07% | 1,079,403 | 216.11M |
| 243 | BNTC | Benitec Biopharma Inc. | 416.20M | -0.16% | 86,207 | - |
| 244 | NGNE | Neurogene Inc. | 413.51M | -3.53% | 246,359 | 925.00K |
| 245 | NMRA | Neumora Therapeutics, Inc. | 411.05M | - | 1,144,144 | - |
| 246 | PRTC | PureTech Health plc | 409.08M | -4.08% | 16,704 | 6.39M |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 402.50M | 1.17% | 118,332 | 66.98M |
| 248 | IPSC | Century Therapeutics, Inc. | 396.13M | - | 463,135 | 109.16M |
| 249 | VTVT | vTv Therapeutics Inc. | 388.05M | -2.19% | 56,383 | 17.00K |
| 250 | IVVD | Invivyd, Inc. | 384.61M | -1.45% | 1,362,092 | 53.43M |
| 251 | NAGE | Niagen Bioscience, Inc. | 381.98M | -1.65% | 612,237 | 129.42M |
| 252 | PBYI | Puma Biotechnology, Inc. | 380.56M | -0.80% | 205,093 | 228.37M |
| 253 | RCKT | Rocket Pharmaceuticals, Inc. | 379.75M | 1.46% | 2,126,555 | - |
| 254 | AUTL | Autolus Therapeutics plc | 375.26M | -4.73% | 1,609,773 | 75.39M |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 372.77M | -0.49% | 327,008 | 35.11M |
| 256 | YDES | YD Bio Limited | 364.92M | -0.20% | 1,571 | 510.36K |
| 257 | LCTX | Lineage Cell Therapeutics, Inc. | 363.67M | -6.41% | 2,285,161 | 14.56M |
| 258 | SRZN | Surrozen, Inc. | 362.52M | 1.87% | 129,520 | 3.48M |
| 259 | AVTX | Avalo Therapeutics, Inc. | 352.63M | 2.64% | 760,752 | 59.00K |
| 260 | ARMP | Armata Pharmaceuticals, Inc. | 349.84M | -2.15% | 70,178 | 4.90M |
| 261 | IMRX | Immuneering Corporation | 339.66M | 0.38% | 563,782 | - |
| 262 | SLN | Silence Therapeutics plc | 335.83M | -7.66% | 501,504 | 559.00K |
| 263 | MNPR | Monopar Therapeutics Inc. | 335.41M | -8.00% | 144,033 | - |
| 264 | IRD | Opus Genetics, Inc. | 333.45M | -6.60% | 1,668,370 | 14.20M |
| 265 | BCYC | Bicycle Therapeutics plc | 329.71M | 0.85% | 441,900 | 72.59M |
| 266 | RZLT | Rezolute, Inc. | 324.08M | 1.63% | 1,254,081 | - |
| 267 | PALI | Palisade Bio, Inc. | 323.13M | -1.03% | 2,185,573 | - |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 321.14M | -4.18% | 114,252 | - |
| 269 | IKT | Inhibikase Therapeutics, Inc. | 317.04M | -1.06% | 553,522 | 1.00 |
| 270 | NAUT | Nautilus Biotechnology, Inc. | 316.41M | -3.47% | 293,477 | - |
| 271 | CABA | Cabaletta Bio, Inc. | 309.48M | -2.80% | 2,409,840 | - |
| 272 | ABEO | Abeona Therapeutics Inc. | 303.75M | -0.37% | 786,754 | 5.82M |
| 273 | NGEN | NervGen Pharma Corp. | 303.49M | -3.35% | 217,454 | - |
| 274 | AVXL | Anavex Life Sciences Corp. | 302.11M | -3.26% | 587,098 | - |
| 275 | CMPX | Compass Therapeutics, Inc. | 300.75M | -9.24% | 24,705,591 | 850.00K |
| 276 | GLSI | Greenwich LifeSciences, Inc. | 299.26M | -5.26% | 154,928 | - |
| 277 | ACIU | AC Immune SA | 290.66M | -3.30% | 173,277 | 4.51M |
| 278 | LENZ | LENZ Therapeutics, Inc. | 283.76M | -2.58% | 587,715 | 19.09M |
| 279 | ZNTL | Zentalis Pharmaceuticals, Inc. | 280.89M | -2.22% | 733,332 | 26.87M |
| 280 | SGMT | Sagimet Biosciences Inc. | 280.23M | -1.71% | 1,589,491 | - |
| 281 | NERV | Minerva Neurosciences, Inc. | 280.15M | -0.78% | 88,328 | - |
| 282 | TARA | Protara Therapeutics, Inc. | 279.62M | 2.17% | 516,087 | - |
| 283 | FHTX | Foghorn Therapeutics Inc. | 279.41M | -7.93% | 130,643 | 30.91M |
| 284 | EDIT | Editas Medicine, Inc. | 276.00M | -7.84% | 1,214,157 | 40.52M |
| 285 | CLLS | Cellectis S.A. | 273.38M | -6.75% | 22,405 | 79.59M |
| 286 | NBP | NovaBridge Biosciences | 271.77M | -1.67% | 4,697,613 | - |
| 287 | CHRS | Coherus Oncology, Inc. | 268.34M | -1.69% | 665,404 | 42.17M |
| 288 | CDXS | Codexis, Inc. | 255.34M | -0.35% | 1,321,614 | 70.39M |
| 289 | ALEC | Alector, Inc. | 253.83M | -3.77% | 368,602 | 21.05M |
| 290 | ELDN | Eledon Pharmaceuticals, Inc. | 253.73M | -4.02% | 1,185,774 | - |
| 291 | CCCC | C4 Therapeutics, Inc. | 249.80M | -6.91% | 1,849,270 | 35.95M |
| 292 | PLYX | Polaryx Therapeutics, Inc. | 247.13M | -7.28% | 72,697 | - |
| 293 | CGEN | Compugen Ltd. | 245.84M | -4.76% | 727,740 | 72.76M |
| 294 | HELP | Cybin Inc. | 245.68M | -4.84% | 1,315,170 | - |
| 295 | SABS | SAB Biotherapeutics, Inc. | 244.56M | -1.42% | 322,059 | 114.70K |
| 296 | ARCT | Arcturus Therapeutics Holdings Inc. | 238.75M | -5.30% | 251,866 | 82.03M |
| 297 | ADAG | Adagene Inc. | 234.56M | 0.57% | 385,585 | 7.67M |
| 298 | SLGL | Sol-Gel Technologies Ltd. | 233.41M | 0.68% | 26,566 | 19.39M |
| 299 | NVCT | Nuvectis Pharma, Inc. | 225.18M | -2.19% | 47,061 | - |
| 300 | HRTX | Heron Therapeutics, Inc. | 224.48M | -1.65% | 1,321,620 | 154.90M |
| 301 | MIST | Milestone Pharmaceuticals Inc. | 223.22M | -1.62% | 656,189 | 1.55M |
| 302 | OBIO | Orchestra BioMed Holdings, Inc. | 222.38M | -2.56% | 241,991 | 33.48M |
| 303 | ACHV | Achieve Life Sciences, Inc. | 220.95M | -2.81% | 380,211 | - |
| 304 | KROS | Keros Therapeutics, Inc. | 219.64M | -2.37% | 209,685 | 244.06M |
| 305 | VYGR | Voyager Therapeutics, Inc. | 216.94M | -3.45% | 343,792 | 40.37M |
| 306 | FENC | Fennec Pharmaceuticals Inc. | 215.81M | -6.57% | 141,831 | 44.64M |
| 307 | ARTV | Artiva Biotherapeutics, Inc. | 215.53M | -3.86% | 242,261 | 251.00K |
| 308 | CNTX | Context Therapeutics Inc. | 215.00M | -6.77% | 794,992 | - |
| 309 | ALXO | ALX Oncology Holdings Inc. | 212.60M | -3.66% | 381,977 | - |
| 310 | MDWD | MediWound Ltd. | 208.85M | -1.87% | 56,175 | 16.96M |
| 311 | CAMP | Camp4 Therapeutics Corporation | 208.22M | -6.09% | 56,841 | 3.50M |
| 312 | OKUR | OnKure Therapeutics, Inc. | 206.02M | -2.30% | 94,285 | - |
| 313 | OABI | OmniAb, Inc. | 196.90M | -2.86% | 527,866 | 18.67M |
| 314 | REPL | Replimune Group, Inc. | 196.52M | -7.39% | 4,019,659 | - |
| 315 | NKTX | Nkarta, Inc. | 191.77M | -2.89% | 866,203 | - |
| 316 | WHWK | Whitehawk Therapeutics, Inc. | 190.67M | -2.18% | 64,298 | 7.15M |
| 317 | ENLV | Enlivex Ltd. | 190.26M | -2.97% | 374,640 | - |
| 318 | ELTX | Elicio Therapeutics, Inc. | 189.85M | -4.44% | 127,776 | - |
| 319 | KPTI | Karyopharm Therapeutics Inc. | 189.36M | -2.33% | 264,677 | 146.07M |
| 320 | MGNX | MacroGenics, Inc. | 186.87M | -2.33% | 423,879 | 149.50M |
| 321 | CRBU | Caribou Biosciences, Inc. | 185.54M | -7.69% | 1,218,408 | 11.16M |
| 322 | HUMA | Humacyte, Inc. | 182.06M | -3.24% | 3,462,702 | 2.04M |
| 323 | KRRO | Korro Bio, Inc. | 181.87M | -1.48% | 72,324 | 6.39M |
| 324 | UNCY | Unicycive Therapeutics, Inc. | 180.70M | -0.14% | 201,723 | - |
| 325 | DTIL | Precision BioSciences, Inc. | 178.04M | -2.82% | 166,365 | 34.26M |
| 326 | CNTN | Canton Strategic Holdings, Inc. | 176.77M | -5.45% | 631,132 | - |
| 327 | TNXP | Tonix Pharmaceuticals Holding Corp. | 176.15M | -2.44% | 306,691 | 13.11M |
| 328 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 174.17M | - | 364,526 | - |
| 329 | RNAC | Cartesian Therapeutics, Inc. | 171.51M | -4.85% | 157,247 | 2.80M |
| 330 | PLX | Protalix BioTherapeutics, Inc. | 170.81M | - | 532,258 | 52.74M |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 168.98M | -4.88% | 278,115 | - |
| 332 | ANTX | AN2 Therapeutics, Inc. | 168.46M | -1.27% | 177,051 | - |
| 333 | MENS | Jyong Biotech Ltd. | 167.64M | 0.46% | 26,213 | - |
| 334 | PRQR | ProQR Therapeutics N.V. | 162.26M | 4.05% | 1,158,780 | 19.19M |
| 335 | TLSA | Tiziana Life Sciences Ltd | 160.81M | 0.80% | 93,780 | - |
| 336 | MOLN | Molecular Partners AG | 159.10M | 3.97% | 1,324 | 856.30K |
| 337 | ORMP | Oramed Pharmaceuticals Inc. | 155.31M | -4.71% | 165,715 | 2.00M |
| 338 | ALPS | Alps Group Inc | 154.75M | -0.84% | 2,827 | 3.74M |
| 339 | SPRB | Spruce Biosciences, Inc. | 150.03M | 1.37% | 47,342 | 697.00K |
| 340 | GALT | Galectin Therapeutics Inc. | 148.11M | -3.02% | 265,011 | - |
| 341 | AGEN | Agenus Inc. | 147.45M | -1.29% | 568,745 | 114.20M |
| 342 | BDTX | Black Diamond Therapeutics, Inc. | 147.23M | -4.81% | 568,137 | 70.00M |
| 343 | SPRO | Spero Therapeutics, Inc. | 146.47M | -5.24% | 828,455 | 66.80M |
| 344 | FATE | Fate Therapeutics, Inc. | 144.17M | -4.62% | 912,025 | 6.65M |
| 345 | TNYA | Tenaya Therapeutics, Inc. | 143.28M | -4.44% | 3,234,078 | - |
| 346 | IFRX | InflaRx N.V. | 143.14M | 18.56% | 2,618,726 | 34.44K |
| 347 | CNTB | Connect Biopharma Holdings Limited | 143.00M | 5.42% | 124,882 | 64.00K |
| 348 | KZIA | Kazia Therapeutics Limited | 141.92M | 4.81% | 247,975 | 1.27M |
| 349 | EDSA | Edesa Biotech, Inc. | 141.28M | 11.50% | 2,246,195 | - |
| 350 | IMUX | Immunic, Inc. | 136.41M | -6.70% | 360,811 | - |
| 351 | HURA | TuHURA Biosciences, Inc. | 133.51M | -1.41% | 417,125 | - |
| 352 | EQ | Equillium, Inc. | 131.51M | 1.46% | 303,723 | 4.39M |
| 353 | IPHA | Innate Pharma S.A. | 131.03M | 5.71% | 67,428 | 10.57M |
| 354 | ACOG | Alpha Cognition Inc. | 127.81M | -5.32% | 28,492 | 10.22M |
| 355 | KLRS | Kalaris Therapeutics, Inc. | 126.33M | -2.30% | 91,721 | - |
| 356 | AARD | Aardvark Therapeutics, Inc. | 113.66M | -6.80% | 106,501 | - |
| 357 | VRCA | Verrica Pharmaceuticals Inc. | 113.04M | 0.77% | 112,390 | 35.58M |
| 358 | VANI | Vivani Medical, Inc. | 111.74M | -3.65% | 153,206 | - |
| 359 | GNLX | Genelux Corporation | 110.93M | -1.19% | 163,993 | 8.00K |
| 360 | CRDF | Cardiff Oncology, Inc. | 110.75M | -3.57% | 469,656 | 593.00K |
| 361 | PEPG | PepGen Inc. | 107.13M | -1.90% | 655,079 | - |
| 362 | NTHI | NeOnc Technologies Holdings, Inc. | 107.12M | -0.23% | 109,155 | 39.99K |
| 363 | SEER | Seer, Inc. | 106.07M | -2.59% | 280,444 | 16.58M |
| 364 | TTRX | Turn Therapeutics Inc. | 105.90M | -1.25% | 18,830 | - |
| 365 | CGTX | Cognition Therapeutics, Inc. | 105.44M | -7.81% | 1,006,880 | - |
| 366 | BMEA | Biomea Fusion, Inc. | 104.83M | -5.23% | 1,530,297 | - |
| 367 | PYXS | Pyxis Oncology, Inc. | 104.30M | -2.35% | 277,973 | 13.86M |
| 368 | KALA | KALA BIO, Inc. | 101.69M | -4.45% | 3,844,744 | - |
| 369 | ONCY | Oncolytics Biotech Inc. | 101.15M | -3.27% | 1,858,710 | - |
| 370 | PMN | ProMIS Neurosciences, Inc. | 99.99M | 2.76% | 34,808 | - |
| 371 | CBUS | Cibus, Inc. | 97.64M | -9.86% | 524,888 | 3.64M |
| 372 | ANIX | Anixa Biosciences, Inc. | 96.56M | -4.32% | 106,673 | - |
| 373 | NRXP | NRx Pharmaceuticals, Inc. | 96.13M | -1.36% | 469,430 | 1.23M |
| 374 | GUTS | Fractyl Health, Inc. | 95.51M | -8.27% | 3,106,130 | 3.00K |
| 375 | COYA | Coya Therapeutics, Inc. | 95.47M | -4.46% | 108,528 | 7.95M |
| 376 | INO | Inovio Pharmaceuticals, Inc. | 91.77M | -2.61% | 1,038,563 | 65.34K |
| 377 | ALDX | Aldeyra Therapeutics, Inc. | 90.27M | -4.46% | 699,606 | - |
| 378 | EXOZ | eXoZymes, Inc. | 87.76M | 0.19% | 1,224 | -700.00 |
| 379 | RANI | Rani Therapeutics Holdings, Inc. | 87.19M | 0.63% | 447,064 | 1.63M |
| 380 | PYPD | PolyPid Ltd. | 86.45M | 2.26% | 41,592 | - |
| 381 | NRXS | NeurAxis, Inc. | 85.60M | -2.23% | 128,326 | 3.57M |
| 382 | PTHS | Pelthos Therapeutics Inc. | 84.19M | 0.48% | 12,650 | 16.80M |
| 383 | LONA | LeonaBio, Inc. | 82.38M | 0.92% | 37,202 | - |
| 384 | GOSS | Gossamer Bio, Inc. | 82.05M | 1.36% | 5,127,916 | 48.47M |
| 385 | ACET | Adicet Bio, Inc. | 82.02M | -0.52% | 100,688 | - |
| 386 | CSBR | Champions Oncology, Inc. | 81.24M | -1.01% | 593 | 57.95M |
| 387 | QTTB | Q32 Bio Inc. | 80.46M | -3.85% | 147,538 | 53.74M |
| 388 | OKYO | OKYO Pharma Limited | 79.77M | -3.80% | 49,391 | - |
| 389 | MAIA | MAIA Biotechnology, Inc. | 78.87M | 4.00% | 1,189,766 | - |
| 390 | ATHE | Alterity Therapeutics Limited | 77.59M | -0.44% | 19,297 | 4.43M |
| 391 | XBIT | XBiotech Inc. | 76.83M | -0.79% | 18,286 | - |
| 392 | ICCC | ImmuCell Corporation | 76.35M | 1.08% | 16,323 | 27.64M |
| 393 | ATYR | aTyr Pharma, Inc. | 75.01M | -3.60% | 999,793 | 190.00K |
| 394 | PLRX | Pliant Therapeutics, Inc. | 74.92M | - | 290,764 | - |
| 395 | GANX | Gain Therapeutics, Inc. | 74.35M | -4.86% | 919,714 | - |
| 396 | PMVP | PMV Pharmaceuticals, Inc. | 74.13M | -2.11% | 205,053 | - |
| 397 | FBIO | Fortress Biotech, Inc. | 71.49M | -0.89% | 151,968 | 63.26M |
| 398 | IBO | Impact BioMedical Inc. | 71.16M | - | 69,856 | 32.00K |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 70.13M | -4.74% | 329,445 | - |
| 400 | FLNA | Filana Therapeutics, Inc. | 69.56M | -7.69% | 433,014 | - |
| 401 | TCRX | TScan Therapeutics, Inc. | 69.12M | -8.73% | 507,770 | 10.33M |
| 402 | OSTX | OS Therapies Incorporated | 68.52M | - | 574,666 | - |
| 403 | ACTU | Actuate Therapeutics, Inc. | 68.29M | -0.69% | 104,343 | - |
| 404 | MCRB | Seres Therapeutics, Inc. | 67.58M | -0.56% | 113,667 | 789.00K |
| 405 | MNOV | MediciNova, Inc. | 67.43M | 0.74% | 5,090 | 409.66K |
| 406 | IMA | ImageneBio, Inc. | 66.33M | 3.13% | 26,313 | 800.00K |
| 407 | IMMP | Immutep Limited | 66.24M | -2.01% | 676,347 | 5.28M |
| 408 | ANVS | Annovis Bio, Inc. | 63.54M | -0.54% | 653,034 | - |
| 409 | ESLA | Estrella Immunopharma, Inc. | 62.72M | -3.92% | 22,604 | - |
| 410 | BYSI | BeyondSpring Inc. | 60.45M | -2.65% | 5,920 | 1.88M |
| 411 | HYFT | MindWalk Holdings Corp. | 59.10M | -4.03% | 262,876 | 20.70M |
| 412 | INKT | MiNK Therapeutics, Inc. | 58.65M | 8.55% | 53,527 | - |
| 413 | IBIO | iBio, Inc. | 58.55M | -0.61% | 927,649 | 300.00K |
| 414 | SGMO | Sangamo Therapeutics, Inc. | 55.02M | -33.93% | 49,165,054 | 39.55M |
| 415 | CING | Cingulate Inc. | 54.77M | 0.64% | 670,536 | - |
| 416 | KZR | Kezar Life Sciences, Inc. | 53.93M | -0.14% | 67,620 | - |
| 417 | PDSB | PDS Biotechnology Corporation | 53.60M | -11.08% | 816,029 | - |
| 418 | TIL | Instil Bio, Inc. | 53.24M | -2.85% | 12,250 | - |
| 419 | ENTX | Entera Bio Ltd. | 52.22M | -0.88% | 83,495 | 42.00K |
| 420 | MGX | Metagenomi Therapeutics, Inc. | 50.79M | -6.25% | 152,915 | 25.21M |
| 421 | RADX | Radiopharm Theranostics Limited | 50.57M | -0.68% | 17,303 | 10.86M |
| 422 | TELO | Telomir Pharmaceuticals, Inc. | 49.85M | - | 200,598 | - |
| 423 | RLYB | Rallybio Corporation | 46.97M | 0.91% | 147,682 | 858.00K |
| 424 | NTRB | Nutriband Inc. | 46.07M | 0.80% | 8,734 | 2.28M |
| 425 | ATOS | Atossa Therapeutics, Inc. | 45.47M | -3.83% | 28,962 | - |
| 426 | HYPD | Hyperion DeFi, Inc. | 45.11M | -7.04% | 437,254 | 813.46K |
| 427 | DWTX | Dogwood Therapeutics, Inc. | 45.09M | - | 77,615 | - |
| 428 | XLO | Xilio Therapeutics, Inc. | 45.05M | -1.64% | 31,253 | 43.77M |
| 429 | MREO | Mereo BioPharma Group plc | 44.12M | -0.68% | 1,356,253 | 500.00K |
| 430 | CUE | Cue Biopharma, Inc. | 42.32M | 4.33% | 85,840 | 27.47M |
| 431 | LITS | Lite Strategy, Inc. | 41.82M | 0.88% | 258,769 | - |
| 432 | LIXT | Lixte Biotechnology Holdings, Inc. | 40.66M | -2.78% | 13,039 | - |
| 433 | PTN | Palatin Technologies, Inc. | 39.98M | -4.43% | 3,675 | 8.96M |
| 434 | PSTV | Plus Therapeutics, Inc. | 38.43M | -5.88% | 127,621 | 5.21M |
| 435 | SNSE | Sensei Biotherapeutics, Inc. | 37.93M | -2.78% | 26,148 | - |
| 436 | ATRA | Atara Biotherapeutics, Inc. | 37.62M | -2.75% | 60,784 | 120.77M |
| 437 | RNXT | RenovoRx, Inc. | 37.44M | -1.06% | 421,249 | 1.12M |
| 438 | ALGS | Aligos Therapeutics, Inc. | 36.94M | -5.09% | 120,024 | 2.19M |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 36.48M | -1.68% | 73,329 | 90.00K |
| 440 | VERU | Veru Inc. | 35.95M | -2.18% | 130,757 | 16.89M |
| 441 | RNTX | Rein Therapeutics Inc. | 35.75M | -12.07% | 671,889 | - |
| 442 | EVAX | Evaxion A/S | 35.53M | -1.39% | 7,372 | 7.53M |
| 443 | INMB | INmune Bio Inc. | 35.36M | -5.00% | 148,732 | 50.00K |
| 444 | PLUR | Pluri Inc. | 34.37M | 1.48% | 1,567 | 1.34M |
| 445 | CRVO | CervoMed Inc. | 33.79M | -1.62% | 26,239 | 4.01M |
| 446 | QNTM | Quantum BioPharma Ltd. | 33.23M | 5.21% | 671,653 | - |
| 447 | HOWL | Werewolf Therapeutics, Inc. | 33.05M | -8.11% | 445,932 | 1.14M |
| 448 | GRCE | Grace Therapeutics, Inc. | 32.50M | - | 482,128 | - |
| 449 | BOLD | Boundless Bio, Inc. | 32.49M | 0.69% | 67,525 | - |
| 450 | NXTC | NextCure, Inc. | 31.83M | -3.35% | 18,215 | - |
| 451 | SKYE | Skye Bioscience, Inc. | 31.41M | -3.87% | 150,179 | - |
| 452 | SNTI | Senti Biosciences Holdings, Inc. | 30.64M | 2.98% | 150,528 | 22.00K |
| 453 | IGC | IGC Pharma, Inc. | 30.61M | -1.18% | 331,422 | 1.11M |
| 454 | DARE | Daré Bioscience, Inc. | 30.57M | -4.11% | 226,094 | 1.03M |
| 455 | BCTX | BriaCell Therapeutics Corp. | 29.15M | -0.99% | 55,575 | - |
| 456 | LSTA | Lisata Therapeutics, Inc. | 29.08M | 0.63% | 61,727 | 170.00K |
| 457 | TVRD | Tvardi Therapeutics, Inc. | 28.71M | -4.38% | 32,730 | - |
| 458 | KYNB | Kyntra Bio, Inc. | 28.53M | - | 3,947 | 6.44M |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 28.39M | -0.72% | 141,543 | - |
| 460 | APLM | Apollomics, Inc. | 28.07M | 1.75% | 2,251 | 8.99M |
| 461 | PLRZ | Polyrizon Ltd. | 28.03M | -4.73% | 34,517 | - |
| 462 | NEUP | Neuphoria Therapeutics Inc. | 27.98M | 1.37% | 51,600 | 14.99M |
| 463 | CELU | Celularity Inc. | 27.68M | -7.69% | 46,967 | 40.58M |
| 464 | DYAI | Dyadic International, Inc. | 27.61M | -6.47% | 364,873 | 3.09M |
| 465 | OTLK | Outlook Therapeutics, Inc. | 26.82M | -2.17% | 3,440,914 | 205.70K |
| 466 | TVGN | Tevogen Bio Holdings Inc. | 26.73M | -1.08% | 10,593 | - |
| 467 | NNVC | NanoViricides, Inc. | 26.35M | 0.83% | 110,036 | - |
| 468 | ABVC | ABVC BioPharma, Inc. | 25.45M | -3.74% | 38,233 | 797.92K |
| 469 | LGVN | Longeveron Inc. | 25.34M | -2.10% | 127,881 | 1.20M |
| 470 | TPST | Tempest Therapeutics, Inc. | 24.96M | 2.96% | 118,356 | - |
| 471 | JSPR | Jasper Therapeutics, Inc. | 24.93M | -4.24% | 129,991 | - |
| 472 | BRNS | Barinthus Biotherapeutics plc | 24.51M | -1.66% | 11,264 | 14.97M |
| 473 | MRKR | Marker Therapeutics, Inc. | 24.18M | 2.11% | 54,446 | 3.55M |
| 474 | AEON | AEON Biopharma, Inc. | 24.16M | -3.02% | 129,859 | - |
| 475 | VTGN | Vistagen Therapeutics, Inc. | 23.61M | -0.12% | 377,622 | 789.00K |
| 476 | CVM | CEL-SCI Corporation | 23.55M | -4.28% | 91,092 | - |
| 477 | SER | Serina Therapeutics, Inc. | 22.53M | -1.08% | 65,059 | 130.00K |
| 478 | CRIS | Curis, Inc. | 22.44M | -3.56% | 544,567 | 9.44M |
| 479 | LTRN | Lantern Pharma Inc. | 22.19M | -11.61% | 210,585 | - |
| 480 | ALLR | Allarity Therapeutics, Inc. | 21.83M | 0.73% | 90,220 | 320.00K |
| 481 | VYNE | VYNE Therapeutics Inc. | 21.19M | -0.63% | 32,596 | 570.00K |
| 482 | XCUR | Exicure, Inc. | 21.10M | -4.61% | 25,075 | 500.00K |
| 483 | QNCX | Quince Therapeutics, Inc. | 20.05M | - | 1,031,504 | - |
| 484 | COCP | Cocrystal Pharma, Inc. | 19.16M | - | 117,789 | - |
| 485 | LPCN | Lipocine Inc. | 18.38M | -0.87% | 183,545 | 1.98M |
| 486 | CVKD | Cadrenal Therapeutics, Inc. | 17.21M | 4.88% | 58,419 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 17.18M | 2.17% | 267,068 | - |
| 488 | PASG | Passage Bio, Inc. | 17.16M | -7.44% | 88,818 | - |
| 489 | LEXX | Lexaria Bioscience Corp. | 17.08M | -21.93% | 791,339 | 368.00K |
| 490 | GNTA | Genenta Science S.p.A. | 16.63M | -1.99% | 21,881 | - |
| 491 | NCEL | NewcelX Ltd. | 15.59M | 2.09% | 21,007 | - |
| 492 | ICU | SeaStar Medical Holding Corporation | 15.46M | -1.28% | 53,996 | 1.23M |
| 493 | OSRH | OSR Holdings, Inc. | 15.24M | -38.19% | 15,426,432 | 2.91M |
| 494 | TOVX | Theriva Biologics, Inc. | 15.14M | -7.67% | 2,856,711 | - |
| 495 | INAB | IN8bio, Inc. | 14.87M | -1.31% | 94,846 | - |
| 496 | HIND | Vyome Holdings, Inc. | 14.32M | -2.86% | 20,932 | 319.71K |
| 497 | CYCN | Cyclerion Therapeutics, Inc. | 14.03M | 9.21% | 269,606 | 2.07M |
| 498 | PHIO | Phio Pharmaceuticals Corp. | 13.71M | -1.67% | 63,137 | - |
| 499 | HOTH | Hoth Therapeutics, Inc. | 13.67M | -2.70% | 345,247 | - |
| 500 | MBRX | Moleculin Biotech, Inc. | 13.39M | -1.95% | 76,277 | - |